Ontology highlight
ABSTRACT: Introduction
Controlling pulmonary Mycobacterium avium complex (MAC) disease is difficult because there is no way to know the clinical stage accurately. There have been few attempts to use cell-mediated immunity for diagnosing the stage. The objective of this study was to characterize cytokine profiles of CD4+T and CD19+B cells that recognize various Mycobacterium avium-associated antigens in different clinical stages of MAC.Methods
A total of 47 MAC patients at different stages based on clinical information (14 before-treatment, 16 on-treatment, and 17 after-treatment) and 17 healthy controls were recruited. Peripheral blood mononuclear cells were cultured with specific antigens (MAV0968, 1160, 1276, and 4925), and the cytokine profiles (IFN-γ, TNF-α, IL-2, IL-10, IL-13, and IL-17) of CD4+/CD3+ and CD19+ cells were analyzed by flow cytometry.Results
The response of Th1 cytokines such as IFN-γ and TNF-α against various antigens was significantly higher in both the on-treatment and after-treatment groups than in the before-treatment group and control (P < 0.01-0.0001 and P < 0.05-0.0001). An analysis of polyfunctional T cells suggested that the presence of IL-2 is closely related to the stage after the start of treatment (P = 0.0309-P < 0.0001) and is involved in memory function. Non-Th1 cytokines, such as IL-10 and IL-17, showed significantly higher responses in the before-treatment group (P < 0.0001 and P < 0.01-0.0001). These responses were not observed with purified protein derivative (PPD). CD19+B cells showed a response similar to that of CD4+T cells.Conclusion
There is a characteristic cytokine profile at each clinical stage of MAC.
SUBMITTER: Yamashita Y
PROVIDER: S-EPMC10380938 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Yamashita Yoshiro Y Yasuda Ikkoh I Tanaka Takeshi T Ikeda Toru T Terada Mayumi M Takaki Masahiro M Tsuchihashi Yoshiko Y Asoh Norichika N Ohara Yukiko Y Enany Shymaa S Kobayashi Haruka H Matsumoto Sohkichi S Morimoto Konosuke K
Frontiers in immunology 20230714
<h4>Introduction</h4>Controlling pulmonary <i>Mycobacterium avium</i> complex (MAC) disease is difficult because there is no way to know the clinical stage accurately. There have been few attempts to use cell-mediated immunity for diagnosing the stage. The objective of this study was to characterize cytokine profiles of CD4+T and CD19+B cells that recognize various <i>Mycobacterium avium</i>-associated antigens in different clinical stages of MAC.<h4>Methods</h4>A total of 47 MAC patients at dif ...[more]